Louisiana has taken a bold step to protect the lives of both the unborn and their mothers by moving to add mifepristone and misoprostol, the drug cocktail used in chemical abortion, to the state’s list of dangerous controlled substances. This bill is crucial to safeguarding women’s health.
The possibility of mifepristone and misoprostol being added to the DEA’s list would be a huge win for the well-being of women, especially in light of mounting evidence suggesting the dangers associated with these drugs. Despite the outcry from some women who believe they are being denied healthcare, this move is fundamentally about prioritizing their safety as well as protecting innocent human life..
The Center for Client Safety’s investigations into cases involving these pills underscores the urgent need for regulation. We have several reports of abortion businesses that are dispensing these drugs in a dangerous manner while also ignoring women’s privacy rights.
The absence of oversight from the Food and Drug Administration (FDA) has exacerbated the problem of women being harmed by chemical abortions, leaving them vulnerable and unprotected. By refusing to monitor these drugs, the FDA is failing in its duty to ensure the safety and well-being of all women. If Louisiana legislators are successful in re-classifying mifepristone and misoprostol, they will be protecting women in a way our politicized federal agencies are not.
At its core, the pro-life stance on this issue is not about denying women access to healthcare or infringing upon their rights. Rather, it is about protecting women from an incredibly dangerous drug that is in the public square despite the harm it can do.
Louisiana’s decision to regulate mifepristone and misoprostol is a crucial step towards safeguarding the lives of both mothers and their unborn children. It is a testament to the state’s unwavering commitment to upholding the sanctity of human life and ensuring that all individuals receive the protection they deserve.
Source: https://www.washingtonpost.com/nation/2024/05/13/abortion-pills-louisiana-controlled-substance/